✦ LIBER ✦

Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma : A retrospective analysis

✍ Scribed by Jason D. Wright; Andrea Hagemann; Janet S. Rader; Dana Viviano; Randall K. Gibb; Lori Norris; David G. Mutch; Matthew A. Powell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tamoxifen therapy in recurrent epithelia

✍ Sheldon A. Weiner; David S. Alberts; Earl A. Surwit; John Davis; David Grosso 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 364 KB

EXPERIENCE OF COMBINATION THERAPY WITH B

✍ M. Takano; Y. Kikuchi; T. Kita; K. Kudoh; M. Kato; T. Yoshikawa; M. Miyamoto; A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

The efficacy and safety of chemotherapy

✍ K. Fuh; A. Alvarez-Secord; W. Huh; T. Tillmanns; K. Moore; K. Bevis; A. ElNaggar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Salvage bevacizumab (rhuMAB VEGF)-based

✍ Bradley J. Monk; Ernest Han; Carol A. Josephs-Cowan; Gordon Pugmire; Robert A. B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Pegylated liposomal doxorubicin as a sin

✍ Keng Shen; Beihua Kong; Yunong Gao; Lingying Wu; Ziting Li; Yile Chen; Mengda Li 📂 Article 📅 2009 🏛 Springer-Verlag ⚖ 360 KB

Phase II Trial of CI-958 in Recurrent Pl

✍ Mark A. Hoffman; John A. Blessing; Mark Morgan 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 34 KB